This is not a Studio

Fontem partners with deep tech startups in health and environment. Our role: turn a promising project into an investable asset — by actively piloting execution between two rounds of financing.

What is it? Learn more
The question we always get asked Not a fund.
Not a studio. An operator.

Fontem is a capital operation platform. We co-invest in deep tech startups in health and environment, and we actively pilot their growth between two rounds of financing — where value is created or destroyed.

Capital
Capital first

Every engagement starts with an equity investment. Our interests are aligned with the founders': no advice without capital, no capital without operation.

Operation
Operations next

Weekly to daily piloting focused on the levers that grow valuation: product execution, commercial traction, team, regulatory milestones, investor narrative.

Network
Right connections, right time

Partner-level introductions, prepared over 6 to 12 months, calibrated for the right investors. Never a market blast — always a targeted match.

Health — MedTech

Medtech, Healthtech, Biotech. We target projects with a validated PoC in a structured regulatory pathway. Commercial traction is delayed — not absent.

Environment — Energy

Cleantech, deep green tech, energy transition. Projects rooted in impact reduction, with a demonstrated PoC and industrial or institutional partners in validation phase.

For founders

From conviction
to closing.

01 2 – 4 weeks
Selection

We analyze the project, market and team in depth. Technical, commercial and regulatory due diligence. We only enter a deal if we believe in the potential and the execution capacity.

Validated PoC Regulatory roadmap Founding team
02 J+30
Investment closing

Term sheet, co-investment, next-round objectives defined together. We formalize the alignment of interests and set up the operational follow-up framework from day one.

Co-investment Next round objectives Follow-up framework
03 6 – 18 months
Operation

The core of our engagement. Weekly to daily piloting on the value-creating levers: product execution, commercial traction, key hires, regulatory milestones, investor narrative.

Weekly reviews Traction & milestones Investor narrative
04 When ready
Next round

When the file is ready — not before. Partner-level introductions, prepared over 6 to 12 months, calibrated for the right investor profiles. We support all the way to closing.

Partner introductions Targeted roadshow Closing

Our projects

8 companies supported
MedTech · Diagnostics 2025
Signature Bioscience

Breast cancer recurrence risk detection via PCR. A fully decentralized precision diagnostics approach.

Discover
MedTech · Robotics 2025
Xivix

Dental surgical robotics. Precision and repeatability for practitioners, directly in the operating room.

Discover
HealthTech · AI 2025
Studia

AI dedicated to medical writing. Accelerates the production of clinical and regulatory dossiers.

Discover
MedTech · Care 2026
Kando

Intelligent voice hub for care. Simplifies coordination between patients and care teams through voice.

Discover
MedTech · Surgery 2026
Unveil Surgical

Real-time ENT surgical navigation. Reduces intraoperative risks through augmented imaging.

Discover
MedTech · Regulatory 2026
NotBody.AI

Certification platform for software medical devices (SaMD). Speeds up regulatory-compliant market entry.

Discover
TechMed · Research 2026
TrialZen

Clinical trials supply chain. Optimizes sourcing and logistics of studies to accelerate execution.

Discover
Studio 2026
We also build

When we identify an opportunity without a suitable lead, Fontem initiates the project, recruits co-founders and pilots the launch.

Learn more
The founders

Three paths,
one shared conviction

Stéphane Dehousse
Stéphane Dehousse
Co-Founder & Managing Partner

Serial entrepreneur and investor. Co-founder of two startup studios, +10 fundraises supported. Pilots operational execution and financing.

Samuël Voccia
Samuël Voccia
Co-Founder & Health Expert

PhD in chemistry, co-founder of ANMI (exit to Telix Pharmaceuticals). Regulatory, patents and scientific evaluation expert on every health deal.

Ludovic Wouters
Ludovic Wouters
Co-Founder & Health Expert

Co-founder and director of ANMI (exit to Telix Pharmaceuticals). Covers industrialization and scale-up on the health vertical.

Territory & ambition

Anchored in Liège,
active in Europe

Liège is our starting point — a dense scientific and industrial ecosystem, anchored by the University of Liège, the CHU hospital, and a tradition of DeepTech innovation. But our deals, partners and investors do not stop at the borders.

MedTech & Diagnostics Health
HealthTech & Medical AI Health
Biotech & Pharma Health
Cleantech & Energy Environment
Deep Green Tech Environment

Let's talk about your project

Before you write, take a moment to prepare :

No need for a deck at this stage. A clear message beats a polished pitch.
Response within 5 business days.

Fontem SRL ❤️ Liège - Belgium